Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Thematic (Sector/Industry)

<ul><li>It was a quiet, holiday-shortened week across US cannabis. The MSOS ETF ended +2.93%, while the global YOLO ETF finished +3.00%.</li><li>YTD, MSOS and YOLO are +24.85% and +12.83%, respectively.</li><li>As we’ve been discussing, the potential for rescheduling continues to drive the outperformance of US operators.</li></ul>

It was a quiet, holiday-shortened week across US cannabis. The MSOS ETF ended +2.93%, while the global YOLO ETF finished +3.00%.YTD, MSOS and YOLO are +24.85% and +12.83%, respectively.As we’ve been discussing, the potential for rescheduling continues to drive the outperformance of US operators.

The Highlights - Cannabis News for the Week Ending January 19, 2024

<ul><li>It was another strong week for cannabis stocks, with the US cannabis MSOS ETF gaining 3.40% and the global YOLO ETF increasing 1.06%.</li><li>Since the US Department of Health and Human Services (HHS) announcement on August 30, MSOS is +69.07%, while YOLO is +34.82%.</li><li>We are in the midst of a catalyst-driven rally, driven by the potential to get to Schedule III and remove the 280E tax burden, which affects plant-touching US operators.</li></ul>

It was another strong week for cannabis stocks, with the US cannabis MSOS ETF gaining 3.40% and the global YOLO ETF increasing 1.06%.Since the US Department of Health and Human Services (HHS) announcement on August 30, MSOS is +69.07%, while YOLO is +34.82%.We are in the midst of a catalyst-driven rally, driven by the potential to get to Schedule III and remove the 280E tax burden, which affects plant-touching US operators.

The Highlights - Cannabis News for the Week Ending January 12, 2024

<ul><li>It was a strong start of the year for cannabis stocks, with the US cannabis MSOS ETF gaining 13.12% and the global YOLO ETF increasing 9.11%.</li><li>US cannabis continues to outperform Canadian and other global names due to the positive sentiment driven by the potential for the DEA to agree with the HHS’s Schedule III recommendation.</li><li>This would eradicate 280E, the onerous tax code that applies to plant-touching US operators.</li></ul>

It was a strong start of the year for cannabis stocks, with the US cannabis MSOS ETF gaining 13.12% and the global YOLO ETF increasing 9.11%.US cannabis continues to outperform Canadian and other global names due to the positive sentiment driven by the potential for the DEA to agree with the HHS’s Schedule III recommendation.This would eradicate 280E, the onerous tax code that applies to plant-touching US operators.

The Highlights - Cannabis News for the Week Ending January 5, 2024

<ul><li>It was another challenging year for the cannabis industry.</li><li>The US cannabis MSOS ETF is in a 1,056-day drawdown and is down 87.29% from peak to trough.</li><li>For the year, MSOS ended +0.29%, while the global YOLO ETF fell 16.11%. US cannabis outperformed global names as the potential for rescheduling affects plant-touching US operators the most.</li></ul>

It was another challenging year for the cannabis industry.The US cannabis MSOS ETF is in a 1,056-day drawdown and is down 87.29% from peak to trough.For the year, MSOS ended +0.29%, while the global YOLO ETF fell 16.11%. US cannabis outperformed global names as the potential for rescheduling affects plant-touching US operators the most.

2023 Year-End Review - Top Three Cannabis-Investing Stories

<ul><li>It was a slightly negative week for most cannabis stocks, with the US-cannabis MSOS ETF dropping 2.11% and the global YOLO ETF ending exactly flat.</li><li>MSOS was -8.87% for the first four days of the week, then presidential pardons and Schedule III speculation sparked a rally.</li><li>On Friday, President Biden issued a proclamation to begin pardoning certain cannabis offenses.</li></ul>

It was a slightly negative week for most cannabis stocks, with the US-cannabis MSOS ETF dropping 2.11% and the global YOLO ETF ending exactly flat.MSOS was -8.87% for the first four days of the week, then presidential pardons and Schedule III speculation sparked a rally.On Friday, President Biden issued a proclamation to begin pardoning certain cannabis offenses.

The Highlights - Cannabis News for the Week Ending December 22, 2023

United States

MariMed, Inc. operates as a pharmaceutical company. The Company specializes in designing, development, operation, funding, and optimization of medical cannabis cultivation, production centers, and dispensaries. MariMed serves customers in the State of Massachusetts.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

MariMed (MRMD US)

The Highlights - Cannabis News for the Week Ending January 19, 2024

It was a quiet, holiday-shortened week across US cannabis. The MSOS ETF ended +2.93%, while the global YOLO ETF finished +3.00%.

Water Tower Research

The Highlights - Cannabis News for the Week Ending January 12, 2024

It was another strong week for cannabis stocks, with the US cannabis MSOS ETF gaining 3.40% and the global YOLO ETF increasing 1.06%.

Water Tower Research

The Highlights - Cannabis News for the Week Ending January 5, 2024

It was a strong start of the year for cannabis stocks, with the US cannabis MSOS ETF gaining 13.12% and the global YOLO ETF increasing 9.11%.

Water Tower Research

2023 Year-End Review - Top Three Cannabis-Investing Stories

It was another challenging year for the cannabis industry. The US cannabis MSOS ETF is in a 1,056-day drawdown and is down 87.29% from peak to trough.

Water Tower Research

The Highlights - Cannabis News for the Week Ending December 22, 2023

It was a slightly negative week for most cannabis stocks, with the US-cannabis MSOS ETF dropping 2.11% and the global YOLO ETF ending exactly flat.

Water Tower Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)